Amulet Capital Appoints Adam Grossman as Partner

Adds Healthcare Investor and Operator with a Track Record of Structuring and Scaling Healthcare Services Platforms

GREENWICH, Conn.--(BUSINESS WIRE)--Amulet Capital Partners, LP (“Amulet”), a middle-market private equity investment firm focused exclusively on the healthcare sector, today announced that Adam Grossman has joined the firm as a Partner. In this role, Mr. Grossman will focus on sourcing, structuring, and working closely with management teams to build and scale healthcare services platforms.

Mr. Grossman brings more than three decades of experience across healthcare operations, corporate strategy, investing, and transaction execution. He began his career in physician practice management as part of the founding team of a multi-market platform, working across strategy, M&A, integration, and practice-level operations during its expansion. He has since held operating, corporate, and investment roles, partnering closely with management teams on growth, capital allocation, and organizational development.

Most recently, Mr. Grossman was a Partner at Deerfield Management, where he led investments in healthcare services and technology-enabled businesses. His work included structuring transactions across equity, debt, and real estate, partnering with strategic counterparties, and serving on the boards of multiple portfolio companies, including Alo Solutions, Vanova Health, and Collage Rehabilitation. Across these roles, he worked closely with management teams on scaling operations, capital structure decisions, and execution at both the strategic and operating level.

Prior to Deerfield, Mr. Grossman served as Senior Vice President of Corporate Development and Operations at The Advisory Board Company (NASDAQ: ABCO), where he led M&A and was a senior member of the team responsible for the company’s strategic review and sale process. He also spent four years at Health Evolution Partners. Previously, he worked at Aetna, where he focused on enterprise strategy and founded Aetna Ventures, the company’s corporate venture investment platform. Earlier in his career, he was a consultant at McKinsey & Company.

“We are excited to welcome Adam to Amulet,” said Ramsey Frank, CEO and Co-Founder of Amulet. “Adam brings a differentiated combination of operating experience and investment judgment. He has consistently demonstrated the ability to structure transactions thoughtfully and work alongside management teams to build scalable healthcare services businesses. His experience aligns directly with how we invest.”

“Adam is someone we have known and worked with for many years,” said Jay Rose, President and Co-Founder of Amulet. “He approaches investing with discipline and a strong sense of partnership, and he has a track record of navigating complex situations and aligning stakeholders over time. We are confident he will be an important contributor as we continue to grow the firm.”

“Having previously served as a Senior Advisor to Amulet, I’ve known Jay, Ramsey, and the rest of the team for many years and have always respected how they approach investing. They are focused, disciplined, and thoughtful about where they spend time and capital. I’m looking forward to working with the team to build healthcare services businesses in areas where we can create real, long-term value,” said Mr. Grossman.

Mr. Grossman received an A.B. from Dartmouth College and an M.B.A. from Harvard University.

About Amulet Capital Partners, LP

Amulet Capital Partners is a middle-market private equity investment firm based in Greenwich, CT, and Walnut Creek, CA, focused exclusively on the healthcare sector. Amulet seeks to achieve long-term capital appreciation through privately negotiated investments in healthcare companies, focusing on those segments it believes have the most attractive long-term fundamentals. Amulet currently manages approximately $2.5 billion in assets and is investing out of its third fund, which was oversubscribed and closed in July 2024 with approximately $1.2 billion in capital commitments. For additional information, please visit www.amuletcapital.com.